Financial Performance - The company's operating revenue for the third quarter was ¥7,290,453,129.77, an increase of 0.26% year-on-year[5] - Net profit attributable to shareholders was ¥14,900,818.83, representing a significant increase of 114.18% compared to the same period last year[5] - The company reported a decrease in net profit attributable to shareholders after deducting non-recurring gains and losses, amounting to -¥2,181,601.45, a decline of 98.49%[5] - Total operating revenue for the current period was ¥21,245,520,041.34, a decrease of 5.55% from ¥22,493,111,043.98 in the previous period[31] - Net profit for the current period was a loss of ¥253,138,793.74, an improvement from a loss of ¥426,192,132.86 in the previous period[32] - The total comprehensive income for the current period was a loss of ¥260,267,288.50, compared to a loss of ¥440,189,463.49 in the previous period[33] - Basic and diluted earnings per share were both -0.0696, an improvement from -0.1351 in the previous period[33] Cash Flow - The net cash flow from operating activities decreased by 67.15% to ¥1,393,589,180.45 due to a reduction in cash received from operating activities[18] - Cash inflow from operating activities totaled ¥27,192,853,928.79, down from ¥31,832,380,207.62 in the previous period[35] - The net cash flow from operating activities was 1,393,589,180.45, a decrease of 67.2% compared to 4,242,725,760.60 from the previous period[36] - Cash outflows from operating activities totaled 25,799,264,748.34, down from 27,589,654,447.02, indicating a reduction of 6.5%[36] - The net cash flow from investing activities was -2,359,594,268.00, slightly improved from -2,440,506,826.18 in the prior period[36] - Cash inflows from financing activities amounted to 14,013,443,723.22, an increase of 19.3% compared to 11,735,819,003.85[37] - The net cash flow from financing activities was 1,776,309,881.16, a significant recovery from -338,320,617.81 in the previous period[37] - The ending balance of cash and cash equivalents was 2,794,082,282.08, down from 3,574,408,444.35, reflecting a decrease of 21.8%[37] - The company paid 9,085,808,853.42 in debt repayments, which increased from 7,038,487,997.63, representing a rise of 29.1%[37] - The total cash outflows related to financing activities were 12,237,133,842.06, slightly up from 12,074,139,621.66, indicating a 1.4% increase[37] - The company received 10,866,615,440.40 in cash from borrowings, which is a slight increase from 10,679,414,047.74, showing a growth of 1.8%[37] Assets and Liabilities - Total assets at the end of the reporting period were ¥78,309,580,150.14, reflecting a 1.67% increase from the previous year[6] - The total assets as of September 30, 2025, amounted to CNY 78.31 billion, an increase from CNY 77.02 billion at the beginning of the period[26] - Current assets reached CNY 15.91 billion, up from CNY 13.12 billion at the start of the period, indicating a growth of approximately 21.2%[27] - The company's cash and cash equivalents increased to CNY 6.83 billion from CNY 4.77 billion, representing a growth of about 43%[26] - Short-term borrowings slightly increased to CNY 5.37 billion from CNY 5.34 billion, showing a marginal rise[28] - Non-current liabilities rose to CNY 19.13 billion from CNY 15.93 billion, reflecting an increase of approximately 20.5%[28] - The total liabilities as of September 30, 2025, were CNY 50.68 billion, compared to CNY 48.98 billion at the beginning of the period, indicating an increase of about 3.5%[28] - Total equity attributable to shareholders of the parent company was ¥21,585,169,660.71, a decrease from ¥21,783,601,095.48 in the previous period[28] Operational Highlights - The company experienced a 36.83% increase in receivables financing, totaling ¥1,056,277,872.65, attributed to an increase in bank acceptance bills[13] - The company’s prepayments increased by 55.21% to ¥891,794,031.34, driven by an increase in advance payments for pulp[13] - The company recorded a 139.82% increase in income tax expenses, amounting to ¥130,152,784.95, due to higher profit levels and an expanded consolidation scope[16] - In Q3 2025, the company produced 1.8758 million tons of PVC resin, 1.3074 million tons of caustic soda, 407,400 tons of viscose fiber, and 228,700 tons of viscose yarn[23] - The company emphasized a market-oriented approach, focusing on differentiated downstream products to enhance market competitiveness[23] - The company aims to strengthen innovation and market collaboration to improve production efficiency and meet market demands[23] Audit and Compliance - The company did not undergo an audit for the third quarter financial report[38]

证券代码：002092 证券简称：中泰化学 公告编号：2025-054 债券代码：148437 债券简称：23 新化 K1 关于终止实施 2021 年限制性股票激励计划 并回购注销限制性股票的公告 新疆中泰化学股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1、2021 年 11 月 12 日，公司七届二十九次董事会、七届二十七次监事会审 议通过了《新疆中泰化学股份有限公司 2021 年限制性股票激励计划（草案）》及 其摘要的议案、关于《新疆中泰化学股份有限公司 2021 年限制性股票激励计划 管理办法》的议案、关于《新疆中泰化学股份有限公司 2021 年限制性股票激励 计划业绩考核办法》的议案。公司独立董事对本次激励计划发表了同意的独立意 见，监事会发表了核查意见。 2、2021 年 12 月 15 日，公司七届三十一次董事会、七届二十八次监事会审 议通过了关于《新疆中泰化学股份有限公司 2021 年限制性股票激励计划（草案 修订稿）》及其摘要的议案、关于《新疆中泰化学股份有限公司 2021 年限制性股 票激励计划管理办法（修订稿）》的议案、关 ...

关于新疆中泰化学股份有限公司 终止实施 2021 年限制性股票激励计划并 回购注销限制性股票相关事项 之 法 律 意 见 书 中国·上海 SHANGHAI·CHINA 上海市浦东东方路 710 号 汤臣国际金融大厦六楼 邮 编 : 200122 电 话 : 86-21-58204822 传 真 : 86-21-58203032 6/F Tomson Financial Building 710 Dong Fang Road Shanghai 200122 P. R. China Tel. : 86-21-58204822 Fax : 86-21-58203032 关于新疆中泰化学股份有限公司终止实施 2021 年限制性股票激励计划并回购注销限制性股票相关事项之 法 律 意 见 书 致：新疆中泰化学股份有限公司 上海市浦栋律师事务所（以下简称"本所"）接受新疆中泰化学股份有限公 司（以下简称"中泰化学"或"公司"）的委托，担任公司 2021 年限制性股票 激励计划（以下简称"激励计划"或"本次激励计划"）相关事宜的专项法律顾 问。 浦 栋 律 师 事 务 所 PU DONG LAW OFFICE 本所根据《中华 ...

二〇二五年十月二十一日 1 董事会薪酬与考核委员会关于终止实施 2021 年限制性股票 激励计划并回购注销限制性股票事项的审核意见 新疆中泰化学股份有限公司 董事会薪酬与考核委员会 新疆中泰化学股份有限公司 新疆中泰化学股份有限公司（以下简称"公司"）依照《公司法》和《公司 章程》的有关规定于2025年10月21日召开了2025年第二次薪酬与考核委员会。经 与会成员认真审议，会议全票表决通过《关于终止实施2021年限制性股票激励计 划并回购注销限制性股票的议案》。公司董事会薪酬与考核委员会对上述事项发 表如下审查意见： 经核查，公司本次终止实施 2021 年限制性股票激励计划并回购注销限制性 股票的行为符合《上市公司股权激励管理办法》及《激励计划》等相关规定，本 次终止激励计划暨回购注销事项不会对公司的财务状况及股东权益产生重大影 响，也不存在损害公司及全体股东利益的情形。薪酬与考核委员会同意本次终止 实施 2021 年限制性股票激励计划并回购注销限制性股票事项，并同意将该事项 提交至公司董事会审议。 ...

Market Overview - As of 14:00, the Shanghai Composite Index is at 3859.80 points, with an increase of 0.52% [1] - The total trading volume of A-shares today is 1,431.28 billion yuan [1] Technical Analysis - A total of 84 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - The stocks with the largest distance between their 5-day and 10-day moving averages include: - Yunnan Zhenye: 5-day MA is -2.45% below the 10-day MA [1] - Qiangli New Materials: 5-day MA is -2.22% below the 10-day MA [1] - Feirongda: 5-day MA is -2.14% below the 10-day MA [1] Individual Stock Performance - Yunnan Zhenye (002428): Today's change is -0.93%, with a 5-day MA of 27.71 yuan and a 10-day MA of 28.41 yuan [1] - Qiangli New Materials (300429): Today's change is +0.53%, with a 5-day MA of 13.95 yuan and a 10-day MA of 14.26 yuan [1] - Feirongda (300602): Today's change is +1.03%, with a 5-day MA of 33.00 yuan and a 10-day MA of 33.72 yuan [1] - Other notable stocks include: - Warner Pharmaceuticals (688799): Today's change is +0.43%, with a 5-day MA of 55.41 yuan [1] - Blue Ying Equipment (300293): Today's change is +0.34%, with a 5-day MA of 24.48 yuan [1] Additional Stock Data - The following stocks also show a downward trend in their 5-day moving averages compared to their 10-day moving averages: - Nanya New Materials (688519): -0.90% change, 5-day MA of 74.18 yuan [1] - Aerospace Morning Light (600501): -2.84% change, 5-day MA of 23.60 yuan [1] - Haichen Pharmaceutical (300584): +1.92% change, 5-day MA of 57.39 yuan [1]

地址：中国.西安曲江雁南五路曲江影视大厦六层、七层、二十五层 电话:(029)68206166 传真:(029)68206135 陕西稼轩律师事务所 关于 新疆中泰化学股份有限公司 2025 年第三次临时股东会之 法律意见书 二〇二五年十月 地址：中国.西安曲江雁南五路曲江影视大厦六层、七层、二十五层 电话:(029)68206166 传真:(029)68206135 关于新疆中泰化学股份有限公司 2025 年第三次临时股东会法律意见书 本所律师仅就本次股东会的召集、召开程序、出席会议人员资格 地址：中国.西安曲江雁南五路曲江影视大厦六层、七层、二十五层 电话:(029)68206166 传真:(029)68206135 及大会表决程序的真实性、完整性、合法性、有效性发表如下法律意 见： 一、本次会议的召集、召开程序 （一）本次会议的召集 经查验，公司董事会于 2025 年 9 月 29 日审议通过了关于召开公 司 2025 年第三次临时股东会的议案，于 2025 年 9 月 30 日在巨潮资 讯网（http://www.cninfo.com.cn）、《证券时报》公开发布了《新疆 中泰化学股份有限公司关于召开 ...

2025年第三次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示 | 证券代码：002092 | 证券简称：ST中泰 | 公告编号：2025-051 | | --- | --- | --- | | 债券代码：148216 | 债券简称：23新化01 | | | 债券代码：148437 | 债券简称：23新化K1 | | 新疆中泰化学股份有限公司 新疆中泰化学股份有限公司（以下简称"公司"）于2025年9月30日在《证券 时报》和巨潮资讯网（www.cninfo.com.cn）上刊登了《新疆中泰化学股份有限 公司关于召开2025年第三次临时股东会通知的公告》。 本次股东会无否决议案的情况，无修改议案的情况，也无新议案提交表决。 一、会议召开基本情况 （一）股东会名称：2025 年第三次临时股东会 （二）会议召集人：公司董事会 （三）会议主持人：董事长黄小虎 （四）本次股东会由公司董事会提议召开，会议的召集程序符合《公司法》、 《深圳证券交易所股票上市规则》等法律、法规、规范性文件及《公司章程》的 规定。 （五）会议时间： 1、现场 ...

债券代码:148437.SZ 债券简称:23 新化 K1 申万宏源证券有限公司关于 新疆中泰化学股份有限公司取消监事会 的临时受托管理事务报告 债券受托管理人 (住所:上海市徐汇区长乐路 989 号 45 层) 2025年10月 重要声明 本报告依据《公司债券发行与交易管理办法》、《公司债券受托管理人执业 行为准则》、《新疆中泰化学股份有限公司 2022 年面向专业投资者公开发行公 司债券受托管理协议》(以下简称"《债券受托管理协议》")及其它相关信息 披露文件以及新疆中泰化学股份有限公司(以下简称"发行人")出具的相关说明 文件和提供的相关资料等,由债券受托管理人申万宏源证券有限公司(以下简称 "申万宏源证券"或"债券受托管理人"）编制。 本报告不构成对投资者进行或不进行某项行为的推荐意见,投资者应对相关 事宜作出独立判断,而不应将本报告中的任何内容据以作为申万宏源证券所作的 承诺或声明。 一、债券的基本情况 1、债券名称 新疆中泰化学股份有限公司 2023 年面向专业投资者公开发行 科技创新公司债券(第一期) 2、发行规模:本期债券发行规模为 6 亿元。 3、债券期限:本期债券发行期限为5年期,在第2年末 ...

证券代码：002092 证券简称：中泰化学 公告编号：2025-048 债券代码：148437 债券简称：23 新化 K1 新疆中泰化学股份有限公司 关于修订《公司章程》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新疆中泰化学股份有限公司（以下简称"公司"或"中泰化学"）于2025年9月29 日召开八届三十次董事会，审议通过了《关于修订<新疆中泰化学股份有限公司 章程>的议案》，具体内容如下： 一、《公司章程》修订情况 根据《上市公司章程指引》《上市公司股东会规则》《深圳证券交易所股票上 市规则》等相关法律、法规和规范性文件的规定，为进一步完善公司治理结构， 加强公司规范运作，结合公司实际情况，公司将不再设置监事会，《公司法》中 规定的监事会职权由董事会审计委员会承接，同时对《公司章程》中相关条款进 行了修订完善。 《公司章程》经股东会审议通过后，公司监事会将停止履职，公司监事自动 解任，《监事会议事规则》等监事会相关制度相应废止，公司各项规章制度中涉 及监事会、监事的规定不再适用。 | 原规定 | | 修订后 | | --- | --- | -- ...

Group 1 - The company Zhongtai Chemical (SZ 002092) announced on September 29 that its 30th board meeting for the eighth session was held via telecommunication, where it reviewed the proposal for appointing the auditing firm for the fiscal year 2025 [1] - For the first half of 2025, Zhongtai Chemical's revenue composition is as follows: Industrial sector accounts for 66.13%, Textile sector for 27.91%, Other businesses for 3.4%, Trade for 1.35%, and Logistics for 1.21% [1] - As of the time of reporting, Zhongtai Chemical has a market capitalization of 11.9 billion yuan [1]